KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,303 | -28.1% | 1,284 | -41.7% | 0.00% | 0.0% |
| Q2 2023 | $31,004 | +58398.1% | 2,202 | -55.2% | 0.00% | -50.0% |
| Q1 2023 | $53 | +307.7% | 4,915 | +437.7% | 0.00% | +100.0% |
| Q4 2022 | $13 | -100.0% | 914 | -70.3% | 0.00% | 0.0% |
| Q3 2022 | $39,000 | -7.1% | 3,077 | -28.1% | 0.00% | 0.0% |
| Q2 2022 | $42,000 | +68.0% | 4,280 | +69.5% | 0.00% | – |
| Q1 2022 | $25,000 | -73.4% | 2,525 | -68.4% | 0.00% | -100.0% |
| Q4 2021 | $94,000 | +88.0% | 7,984 | +78.5% | 0.00% | +100.0% |
| Q3 2021 | $50,000 | -35.1% | 4,474 | -18.7% | 0.00% | -50.0% |
| Q2 2021 | $77,000 | +208.0% | 5,501 | +312.4% | 0.00% | – |
| Q1 2021 | $25,000 | -49.0% | 1,334 | -51.5% | 0.00% | -100.0% |
| Q4 2020 | $49,000 | -83.6% | 2,750 | -85.8% | 0.00% | -66.7% |
| Q3 2020 | $298,000 | +338.2% | 19,421 | +622.5% | 0.00% | 0.0% |
| Q2 2020 | $68,000 | +209.1% | 2,688 | +87.4% | 0.00% | +200.0% |
| Q1 2020 | $22,000 | -71.1% | 1,434 | -79.0% | 0.00% | -83.3% |
| Q4 2019 | $76,000 | – | 6,814 | +22613.3% | 0.01% | – |
| Q3 2019 | $0 | -100.0% | 30 | -94.0% | 0.00% | -100.0% |
| Q1 2019 | $9,000 | -71.0% | 498 | -58.5% | 0.00% | -50.0% |
| Q3 2018 | $31,000 | +675.0% | 1,199 | +421.3% | 0.00% | – |
| Q2 2018 | $4,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |